# NRX Pharmaceuticals, Inc.: Form 8-K, filed Oct 16, 2026

- Company: [NRX Pharmaceuticals, Inc.](/companies/nrxp.md) (CIK 1719406)
- Form: 8-K
- Filed: 2026-10-16
- Accepted by EDGAR: Oct 16, 2026, 17:16 ET
- Period: 2026-10-16
- Accession: 0001437749-26-032828
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1719406/000143774926032828/nrxp20261014_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1719406/000143774926032828/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1719406/000143774926032828/nrxp20261014_8k.htm

Filed Oct 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-032828. Last ingested by Listed: Nov 5, 2026, 19:01 ET. No prices; not investment advice.